Business · 22/05/2026Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting to Discuss Safety and Effectiveness of Moderna's MFLUSIVA Influenza Vaccine
Summary
The FDA is hosting a public meeting of the Vaccines and Related Biological Products Advisory Committee to gather input on the safety and effectiveness of Moderna's MFLUSIVA influenza vaccine, and is seeking public comments on the matter
Original source language: Federal Register — Health and Human ServicesOpen original release →